Multiple Assemblies exist for SMTL entry 3vqs
Crystal structure of HCV NS5B RNA polymerase with a novel piperazine inhibitor; X-RAY DIFFRACTION 1.90 Å

	SMTL ID 3vqs.1 Ligands (2R)-4-(5-cyclopropyl[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-[3-fluoro-4-(trifluoromethoxy)benzyl]-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine-2-carboxamide Polypeptides RNA-directed RNA polymerase Oligo-state monomer
	SMTL ID 3vqs.2 Ligands (2R)-4-(5-cyclopropyl[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-[3-fluoro-4-(trifluoromethoxy)benzyl]-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine-2-carboxamide; CHLORIDE ION Polypeptides RNA-directed RNA polymerase Oligo-state monomer
	SMTL ID 3vqs.3 Ligands (2R)-4-(5-cyclopropyl[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-[3-fluoro-4-(trifluoromethoxy)benzyl]-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine-2-carboxamide; CHLORIDE ION Polypeptides RNA-directed RNA polymerase Oligo-state monomer
	SMTL ID 3vqs.4 Ligands (2R)-4-(5-cyclopropyl[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-[3-fluoro-4-(trifluoromethoxy)benzyl]-1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine-2-carboxamide Polypeptides RNA-directed RNA polymerase Oligo-state monomer